Key Takeaways Olin posted a Q4 net loss of $85.7M, versus a year-ago profit, as revenues dipped slightly year over year.OLN faced pricing pressure in Chlor Alkali, swinging the segment to a loss.Olin expects Q1 EBITDA to drop from Q4 levels on higher maintenance and raw material costs.Olin Corporation (OLN) posted a fourth-quarter 2025 loss of $85.7 million or 75 cents per share. This compares to a profit of $10.7 million or 9 cents in the year-ago quarter. Barring one-time items, losses came in at 58 cents ...

Olin (NYSE:OLN) Q4 2025 Earnings call January 30, 2026 09:00 AM ET Company ParticipantsAleksey Yefremov - Managing DirectorDavid Begleiter - Managing DirectorFrank Mitsch - Managing DirectorJeff Zekauskas - Managing DirectorJohn Roberts - Managing DirectorJosh Spector - Executive DirectorKen Lane - President and CEOKevin McCarthy - PartnerMatthew Blair - Managing DirectorMike Sison - Managing DirectorSteve Keenan - Head of Investor RelationsTodd Slater - CFOVincent Andrews - Managing DirectorConference Call ...

4Q25 & FY25 Earnings Call J a n u a r y 3 0 , 2 0 2 6 Forward-looking Statements 1 Value-first commercial approach continues to preserve ECU values 2 Announced Braskem long-term agreement, upgrading our export EDC values 3 Successful Epoxy volume growth amid European capacity closures 4 Winchester reduced commercial production accelerating destocking 5 Generated $321M of operating cash flow, keeping net debt flat year-over-year Chlor Alkali Products & Vinyls Segment Performance This presentation includes fo ...

Core Insights - Olin reported revenue of $1.67 billion for the quarter ended December 2025, a decrease of 0.4% year-over-year, with an EPS of -$0.58 compared to $0.09 in the same quarter last year [1] - The revenue exceeded the Zacks Consensus Estimate by 5.33%, while the EPS was slightly below the consensus estimate [1] Financial Performance - Olin's sales in the Epoxy segment reached $359.3 million, surpassing the average estimate of $293.07 million by 27.3% year-over-year [4] - Sales from Chlor Alkali Products and Vinyls were $856.4 million, slightly above the average estimate of $854.77 million, but represented a year-over-year decline of 10.2% [4] - Winchester sales amounted to $449.4 million, exceeding the estimated $406.54 million, reflecting a 3.2% increase compared to the previous year [4] Income Metrics - The income (loss) before taxes for Chlor Alkali Products and Vinyls was -$14.7 million, significantly below the average estimate of $46.26 million [4] - Winchester's income (loss) before taxes was $0.6 million, also below the average estimate of $7.84 million [4] - The income (loss) before taxes for the Epoxy segment was -$19.2 million, better than the average estimate of -$41.15 million [4] Stock Performance - Olin's shares have returned +9.2% over the past month, outperforming the Zacks S&P 500 composite, which saw a +0.8% change [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]

Core Viewpoint - Olin Corporation's near-term performance is under pressure due to macroeconomic factors such as weak demand, industry oversupply, and high leverage, which pose risks to growth [1][10]. Group 1: Near-Term Concerns - Olin's chlor-alkali and related chemical businesses are experiencing weak demand and oversupply, negatively impacting pricing and profit margins, particularly for caustic soda [2][10]. - The Epoxy segment is facing challenges from subsidized Asian imports and slow recovery in U.S. markets for construction, automotive, and consumer electronics, leading to increased uncertainty regarding chemical demand recovery [2][10]. - High debt levels are constraining Olin's financial flexibility, with total debt unchanged from the previous year, maintaining elevated leverage and increasing exposure to interest rate fluctuations [3]. Group 2: Winchester Segment Challenges - The Winchester segment is facing pressure from rising metal input costs, especially copper, which is expected to increase further, while retailers are destocking due to slow consumer spending [4][10]. - Olin has implemented production cuts and shifted to a make-to-order model to align output with demand and limit inventory build [4]. Group 3: Long-Term Opportunities - Olin is expected to benefit from ongoing cost-saving initiatives and clean hydrogen tax credits, which will enhance margins and cash flow generation [5][10]. - The Beyond250 cost-savings program aims to deliver $70 million to $90 million in annual savings, focusing on operational efficiencies and manufacturing discipline, with benefits expected to become visible from late 2025 [7]. - Olin is positioned to take advantage of the U.S. Clean Hydrogen Production Tax Credit, which will contribute to improved adjusted EBITDA through its chlor-alkali business [8]. Group 4: Market Performance - Olin's shares have declined by 2% over the past six months, compared to a 14% decline in the industry [9].

Core Insights - Olin Corporation reported a profit of $42.8 million for Q3 2025, a significant recovery from a loss of $24.9 million in the same quarter last year, with earnings per share at 37 cents compared to a loss of 21 cents [1][8] - Revenue increased by approximately 7.8% year over year to $1,713.2 million, although it fell short of the Zacks Consensus Estimate of $1,731.5 million due to constrained demand growth [2][8] Segment Review - **Chlor Alkali Products and Vinyls**: Revenues reached $924 million, up around 6% year over year, but missed the consensus estimate of $992 million. Segment earnings improved to $127.6 million from $45.3 million in Q3 2024 [3] - **Epoxy**: Revenues increased by approximately 22.6% year over year to $349.6 million, surpassing the consensus estimate of $321 million [3] - **Winchester**: Revenues rose about 1.6% year over year to $439.6 million, driven by higher military sales, although it missed the consensus estimate of $448 million [4] Financials - Olin's cash balance at the end of Q3 was $140.3 million, with a net debt of approximately $2.85 billion. The company repurchased about 0.5 million shares for $10.1 million during the quarter, maintaining around $2 billion in share repurchase authorizations [5] Outlook - The company anticipates Q4 2025 adjusted EBITDA to be between $110 million and $130 million, citing seasonal weakness and ongoing market challenges. Olin emphasizes a disciplined capital allocation strategy to maximize cash generation while maintaining net debt levels [6][8] Price Performance - Olin's shares have declined by 40.6% over the past year, compared to a 25.2% decline in the industry [7]

Financial Performance - Q3 2025 - Chlor Alkali Products & Vinyls segment sales were $924 million, with adjusted EBITDA of $237 million[11, 12] - Epoxy segment sales were $350 million, with an adjusted EBITDA loss of $19 million[18] - Winchester segment sales were $440 million, with adjusted EBITDA of $33 million[24] - Olin Corporation's Q3 2025 Adjusted EBITDA was $222.4 million, compared to $176.1 million in Q2 2025 and $160.3 million in Q3 2024[60, 62] Key Highlights & Actions - Olin recognized a $32 million net benefit from Section 45V Clean Hydrogen Production tax credits in the Chlor Alkali Products & Vinyls segment[16] - Winchester is shifting production toward international military sales and lowering commercial production to reduce inventory levels[29] - The company expects to lower current debt levels, targeting year-end 2025 net debt comparable to year-end 2024[36] Outlook - Q4 2025 - Olin anticipates Q4 2025 adjusted EBITDA to be between $110 million and $130 million, including a ~$40 million penalty from planned inventory reductions[38] - The company expects caustic soda price improvement and aims to preserve ECU values despite seasonally weak demand in the CAPV segment[38] - Olin plans aggressive inventory reductions and will execute the Freeport turnaround safely and on budget[38]

Core Insights - Olin reported revenue of $1.71 billion for the quarter ended September 2025, reflecting a year-over-year increase of 7.8% [1] - The company's EPS was $0.40, a significant improvement from -$0.21 in the same quarter last year, resulting in an EPS surprise of +344.44% compared to the consensus estimate of $0.09 [1] Revenue Performance - Epoxy sales reached $349.6 million, exceeding the average estimate of $320.9 million, marking a year-over-year increase of 22.6% [4] - Chlor Alkali Products and Vinyls generated $924 million in sales, below the estimated $992.33 million, but still showing a 6% increase from the previous year [4] - Winchester sales amounted to $439.6 million, slightly below the average estimate of $448.42 million, with a year-over-year growth of 1.6% [4] Income Before Taxes - Income before taxes for Chlor Alkali Products and Vinyls was $127.6 million, surpassing the average estimate of $86.94 million [4] - Winchester's income before taxes was $19.3 million, lower than the estimated $23.86 million [4] - Epoxy reported a loss before taxes of $-32.2 million, which was worse than the average estimate of $-19.35 million [4] Stock Performance - Olin's shares returned +0.4% over the past month, underperforming the Zacks S&P 500 composite's +2.5% change [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance in the near term [3]

Core Insights - Olin Corporation (OLN) reported a second-quarter 2025 loss of $1.3 million, or a loss of $0.01 per share, compared to a profit of $74.2 million, or $0.62 per share, in the same quarter last year. Excluding one-time items, earnings were $0.05 per share [1][7] - Revenues increased by approximately 6.9% year over year to $1,758.3 million, surpassing the Zacks Consensus Estimate of $1,669.1 million [1][7] Segment Review - **Chlor Alkali Products and Vinyls**: Revenues reached $979.5 million, up around 6.4% year over year, exceeding the consensus estimate of $955.4 million. Segment earnings were $64.9 million, down from $99.3 million in Q2 2024 [2] - **Epoxy**: Revenues rose approximately 4.2% year over year to $331.2 million, beating the consensus estimate of $305.9 million [3] - **Winchester**: Revenues increased by about 10.2% year over year to $447.6 million, driven by higher military sales, surpassing the consensus estimate of $401.9 million [3] Financials - Olin's cash balance at the end of Q2 was $223.8 million, with a net debt of approximately $2.8 billion. The company repurchased around 0.5 million shares for $10.1 million during the quarter, with about $2 billion remaining in share repurchase authorizations [4] Outlook - Olin anticipates adjusted EBITDA for Q3 2025 to be between $170 million and $210 million, citing ongoing market challenges and potential rising costs. The company emphasizes a disciplined capital allocation strategy focused on maximizing cash generation [5] Price Performance - Olin's shares have declined by 54.1% over the past year, compared to a 19.4% decline in the industry [6]

Core Viewpoint - Olin Corporation reported a significant decline in net income for the first quarter of 2025, with adjusted earnings surpassing expectations despite lower overall revenues and EBITDA [1][2]. Financial Performance - Net income for Q1 2025 was $1.4 million, down from $48.6 million in the prior-year quarter [1]. - Adjusted earnings were 4 cents per share, beating the Zacks Consensus Estimate of a loss of 10 cents [1]. - Adjusted EBITDA decreased to $185.6 million from $242.1 million year-over-year [1]. Revenue Analysis - Total revenues for Q1 2025 were $1,644.2 million, slightly missing the Zacks Consensus Estimate of $1,661.2 million but showing a year-over-year increase of approximately 0.54% [2]. - Chlor Alkali Products and Vinyls segment revenues rose to $924.5 million, a 4.5% increase year-over-year, exceeding the consensus estimate of $923 million [2]. - Epoxy segment revenues fell by about 2.8% to $331.7 million, surpassing the consensus estimate of $329 million [3]. - Winchester segment revenues declined by approximately 5.2% to $388 million, missing the consensus estimate of $410 million [3]. Cash Flow and Share Repurchase - The company repurchased 0.7 million shares for $20.2 million during the quarter [4]. - Cash flow from operating activities turned negative, with an outflow of $86 million compared to an inflow of $81 million in the prior year [4]. Future Outlook - For Q2 2025, Olin expects results from its Chemicals businesses to remain similar to Q1, with anticipated adjusted EBITDA between $170 million and $210 million [5][6]. - The company forecasts improved performance in the Winchester unit due to seasonal demand and military sales [5]. Stock Performance - Olin's stock has experienced a 63.1% decline over the past year, compared to a 28.3% decline in the industry [7].